FindTrial
Sign In

Evaluation of Heart Disease Risk Using Blood Sugar and Blood Fat Levels in Adults with Type 2 Diabetes

ASSESSING THE TRIGLYCERIDE GLUCOSE INDEX AND TRIGLYCERIDE HDL RATIO FOR EVALUATION OF CARDIOVASCULAR RISK IN ADULTS WITH TYPE 2 DIABETES MELLITUS A CASE CONTROL STUDY - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098713
Enrollment
390
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

Intervention1: Nil: Nil

Sponsors

dr mohammad mazahar jamal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case: Diagnosed cases of type 2 diabetes mellitus (as per ADA criteria), of any duration, either sex, with Cardiovascular Disorders. Patients willing to provide informed consent. Control: Diagnosed cases of type 2 diabetes mellitus (as per ADA criteria), of any duration, either sex, without Cardiovascular disorders. Patients willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Pregnant or Lactating women. Severe Comorbidities Chronic kidney disease Liver failure Cancer Patients with uncontrolled hypothyroidism. HIV/ HBsAg / HCV positive Patients. Patients on Corticosteroids, Antiretroviral medications

Design outcomes

Primary

MeasureTime frame
A strong correlation between elevated TG HDL ratio and TyG index with increased incidence of cardiovascular events in Type 2 diabetes patients Identification of optimal cutoff values for both markers aiding in early risk stratification Potential recommendation for incorporating these indices into routine cardiovascular risk assessment for diabetic patients Timepoint: within 24 months—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Prabha Verma

GSVM Medical College Kanpur

drprabhaverma941@gmail.com9415924237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026